University Hospital Hamburg-Eppendorf

Hamburg D-20246

4 studies enrolling now · 13 studies all time

What they study most

Advanced Solid Tumor, Age-related Macular Degeneration (AMD), Duchenne Muscular Dystrophy, Geographic Atrophy (GA), Hematologic Malignancy, Hemophilia B, MF, Mucopolysaccharidosis III-B, Mucopolysaccharidosis Type 3 B, Myelofibrosis, Post-ET Myelofibrosis, Post-PV MF

Studies at this site

• A Study to Investigate the Safety and Effectiveness of a Coagulation Factor IX Gene Insertion Therapy (REGV131-LNP1265) in Pediatric, Adolescent and Adult Participants With Hemophilia B — Recruiting now
• A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy — Recruiting now
• A Trial to Learn How Well Linvoseltamab Works Compared to the Combination of Elotuzumab, Pomalidomide and Dexamethasone for Adult Participants With Relapsed/Refractory Multiple Myeloma — Recruiting now
• Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib — Recruiting now
• A Trial That Evaluates Disease Characteristics in Hemophilia B Adult Male Participants Receiving Prophylaxis With Standard of Care Factor IX Protein (FIX) Replacement Therapy — Running, not enrolling
• Phase 3 Study of Pelabresib (CPI-0610) in Myelofibrosis (MF) (MANIFEST-2) — Running, not enrolling
• A Long-term Follow-up Study of Subjects Who Received CRISPR CAR T Cellular Therapies — Enrolling by invitation
• Study to Assess AFM24 in Advanced Solid Cancers — Stopped early
• A Gene Transfer Therapy Study to Evaluate the Safety and Efficacy of Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD) — Completed
• Non-comparative Study of IFX-1 Alone or IFX-1+Pembrolizumab in Patients With Locally Advanced or Metastatic cSCC. — Stopped early
• SUrgical Versus PERcutaneous AXillary Artery International Registry — Completed
• A Long-term Follow-up Study of Patients With MPS IIIB Treated With ABO-101 — Stopped early
• Gene Transfer Clinical Trial for Mucopolysaccharidosis (MPS) IIIB — Stopped early